Abstract:
Objective This study aimed to determine the protective effect of levocarnitine on myocardial injury caused by daunorubicin(DNR).
Methods Neonatal cardiomyocytes(aged 5 days) from trained Wister rats were randomly divided into the following groups: normal control group, low DNR injury group, and levocarnitine protection group. High-dose DNR was administered and the cardiomyocytes were cultured for 24 h. Cell viability, lactate dehydrogenase(LDH) release, superoxide dismutase(SOD) activity, and malondialdehyde(MDA) content were determined.
Results The levocarnitine dose could significantly improve the survival rate of damaged myocardial cells, inhibit LDH release, and reduce MDA production and SOD activity.
Conclusion Levocarnitine exhibited a protective effect on DNRiamycin-induced myocardial cell injury.